Venetoclax and Decitabine in Treating Participants With Relapsed/Refractory Acute Myeloid Leukemia or Relapsed High-Risk Myelodysplastic Syndrome
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Immune Oncology Research Institute
Senti Biosciences
Dana-Farber Cancer Institute
MacroGenics
Institute of Hematology and Blood Transfusion, Czech Republic
French Innovative Leukemia Organisation
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
Fred Hutchinson Cancer Center
Mayo Clinic
City of Hope Medical Center
Fred Hutchinson Cancer Center
Orca Biosystems, Inc.
Therapeutic Advances in Childhood Leukemia Consortium
Chongqing Precision Biotech Co., Ltd
Stemline Therapeutics, Inc.
M.D. Anderson Cancer Center
Mustang Bio
Mustang Bio
Chongqing Precision Biotech Co., Ltd
Xencor, Inc.
Samsung Medical Center
Fred Hutchinson Cancer Center
Mayo Clinic
Cellectis S.A.
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
Centre Hospitalier Universitaire de Besancon
National Cancer Institute (NCI)